Viking Global Opportunities Parent GP LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PROCEPT BioRobotics Corp, Amylyx Pharmaceuticals, Inc., RayzeBio, Inc., 4D Molecular Therapeutics, Inc., Roivant Sciences Ltd., BridgeBio Pharma, Inc., Ginkgo Bioworks Holdings, Inc., Rallybio Corp, Frazier Lifesciences Acquisition Corp, Inhibrx, Inc., APi Group Corp, STANDARD BIOTOOLS INC., and Inhibrx Biosciences, Inc..
SEC CIK
Viking Global Opportunities Parent GP LLC's CIK is 0001886738